Nakajo-Nishimura Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Nakajo-Nishimura Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2/3

NCT04517253

A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS

The main purpose of this study is to evaluate the efficacy and safety of baricitinib in adult and pediatric Japanese participants with Nakajo-Nishimura Syndrome…

Japan10 participantsStarted 2020-10-27

Treatment: Baricitinib